Skip to main content
TGTX logo

TGTX · Tg Therapeutics, Inc.

$53.50 +0.02 (+0.04%)
Market Cap
$8.19B
Shares
153.08M

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

The Jun 30, 2026 filing window is still open — showing the latest known positions. Funds that have not filed yet carry their prior-quarter positions; a fund that filed without this stock counts as sold out.
Holders: 391
Total Value: $3,479,549,390
Total Shares: 101,501,178
Showing 1–100 of 410 holdings by value · page 1 of 5

Institutional Ownership Trend

26 quarters

Holder Concentration

Across 366 13F filers
Top Holder
22.0%
Jun 2023 → Mar 2026 · range 13.0% – 22.0%
of institutional value
Top 5
44.4%
Jun 2023 → Mar 2026 · range 36.7% – 52.0%
of institutional value
Top 10
58.3%
Jun 2023 → Mar 2026 · range 53.4% – 62.5%
of institutional value
HHI
697
Jun 2023 → Mar 2026 · range 435 – 818
Broadly held
Showing 100 of 410
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 1001316 CUSIP 88322Q108 13F (30d) 116 filings 116 filers Visit website Investor relations